Published in Gastrointest Endosc on March 01, 2011
Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer (2015) 1.25
Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol (2014) 0.99
Reducing racial and ethnic disparities in colorectal cancer screening is likely to require more than access to care. Health Aff (Millwood) (2012) 0.99
Public awareness of colon cancer screening among the general population: A study from the Western Region of Saudi Arabia. Qatar Med J (2014) 0.83
Quantifying the benefit of screening colonoscopy. Gastrointest Endosc (2011) 0.82
The effect of marriage on utilization of colorectal endoscopy exam in the United States. Cancer Epidemiol (2012) 0.82
Socioeconomic Disparities in Colorectal Cancer Screening in Korea: A Nationwide Cross-Sectional Study. Medicine (Baltimore) (2015) 0.78
Color reproduction and processing algorithm based on real-time mapping for endoscopic images. Springerplus (2016) 0.78
Opportunities and challenges for the use of large-scale surveys in public health research: a comparison of the assessment of cancer screening behaviors. Cancer Epidemiol Biomarkers Prev (2014) 0.76
Screening for Familial Colorectal Cancer Risk amongst Colonoscopy Patients New to an Open-Access Endoscopy Center. ISRN Gastroenterol (2012) 0.75
Colonoscopy Screening among Native Hawaiians at Queen's Medical Center between August 2011 and January 2013. Hawaii J Med Public Health (2016) 0.75
Flexible sigmoidoscopy: more than a unilateral breast exam? Dig Dis Sci (2015) 0.75
Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med (2012) 16.55
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol (2007) 8.05
Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 6.99
Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet (2008) 6.97
Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet (2008) 6.75
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst (2009) 6.21
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet (2011) 5.18
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst (2010) 3.18
Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol (2009) 3.14
Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. Gastroenterology (2011) 3.08
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07
Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. J Natl Cancer Inst (2010) 3.05
Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem (2004) 2.95
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57
Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004. J Natl Cancer Inst (2008) 2.56
Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med (2012) 2.42
Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev (2012) 2.39
Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet (2011) 2.35
Low-dose aspirin use and performance of immunochemical fecal occult blood tests. JAMA (2010) 2.32
Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med (2014) 2.31
Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med (2010) 2.27
Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease. Eur Heart J (2008) 2.26
Cost-effectiveness of colorectal cancer screening. Epidemiol Rev (2011) 2.24
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol (2013) 2.18
Socioeconomic deprivation and cancer survival in Germany: an ecological analysis in 200 districts in Germany. Int J Cancer (2013) 2.18
Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J (2005) 2.16
Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study. Nephrol Dial Transplant (2010) 2.03
Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol Biomarkers Prev (2007) 2.00
Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist (2010) 1.94
The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer (2008) 1.93
Older smokers' motivation and attempts to quit smoking: epidemiological insight into the question of lifestyle versus addiction. Dtsch Arztebl Int (2009) 1.92
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet (2013) 1.88
Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med (2009) 1.84
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81
Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol (2012) 1.80
Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol (2004) 1.80
Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut (2007) 1.79
Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology (2012) 1.79
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet (2013) 1.78
A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression. Med Decis Making (2011) 1.77
Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites. Hum Mol Genet (2013) 1.77
Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. Clin Chem (2012) 1.76
Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy. Gastroenterology (2009) 1.75
Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin Chem (2006) 1.75
Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS One (2008) 1.75
Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany. Am J Epidemiol (2012) 1.74
Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Arch Intern Med (2006) 1.73
Clarifying differences in natural history between models of screening: the case of colorectal cancer. Med Decis Making (2011) 1.71
The performance of methods for correcting measurement error in case-control studies. Epidemiology (2002) 1.71
Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer (2010) 1.69
A systematic review of leukocyte telomere length and age in adults. Ageing Res Rev (2013) 1.67
Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood (2008) 1.65
Calcium, phosphate and the risk of cardiovascular events and all-cause mortality in a population with stable coronary heart disease. Heart (2012) 1.64
Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies. Ann Intern Med (2013) 1.62
Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr (2013) 1.62
Flexible matching strategies to increase power and efficiency to detect and estimate gene-environment interactions in case-control studies. Am J Epidemiol (2002) 1.60
MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev (2011) 1.60
Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res (2012) 1.58
Impact of national smoke-free legislation on home smoking bans: findings from the International Tobacco Control Policy Evaluation Project Europe Surveys. Tob Control (2012) 1.56
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet (2013) 1.56
Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress. Arterioscler Thromb Vasc Biol (2006) 1.56
Epidemiology of Helicobacter pylori infection. Helicobacter (2004) 1.56
Assisted reproductive techniques and risk of exstrophy-epispadias complex: a German case-control study. J Urol (2012) 1.55
Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests. Int J Cancer (2010) 1.55
State disparities in colorectal cancer mortality patterns in the United States. Cancer Epidemiol Biomarkers Prev (2011) 1.54
Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies. Eur J Cancer (2009) 1.53
Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut (2012) 1.52
Recurrent abdominal pain in children: evidence from a population-based study that social and familial factors play a major role but not Helicobacter pylori infection. J Psychosom Res (2003) 1.51
Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J (2012) 1.51
Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics (2009) 1.48
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet (2012) 1.47
High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality. Eur Heart J (2013) 1.46
Multiple tumours in survival estimates. Eur J Cancer (2009) 1.46
Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy. Leuk Lymphoma (2009) 1.46
Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data. Oncologist (2011) 1.45
Physical activity, coronary heart disease, and inflammatory response. Arch Intern Med (2003) 1.44
Cancer survival in a southern African urban population. Int J Cancer (2004) 1.41
Provider delay among patients with breast cancer in Germany: a population-based study. J Clin Oncol (2003) 1.41
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet (2013) 1.39
Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. PLoS One (2013) 1.39
Cancer survival differences between European countries and an urban population from the Philippines. Eur J Public Health (2010) 1.38